Skip to main content
Have a personal or library account? Click to login
Trends in vascular pharmacology research in the Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, Bratislava Cover

Trends in vascular pharmacology research in the Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, Bratislava

Open Access
|Apr 2011

References

  1. Babál P, Kristová V, Černá A, Janega P, Pecháňová O, Danihel Ľ, Andriantsitohaina R. (2006). Red wine polyphenols prevent endothelial damage induced by CCl 4 administration.: 245-251.
  2. Babál P, Kristová V, Kriška M. (1996). Decreased endothelial loss after sulodexide administration assessed by in vitro vessel perfusion.: 119-126.
  3. Babál P, Krišká M, Kristová V, Caňova R. (1992). Evaluation of endothelium loss by in vitro vessel perfusion using Millipore filters.: 359-362.
  4. Babál P, Kriška M, Kristová V, Jakubovský J, Caňová R. (1987). Morphological changes of the arterial duct endothelium in conditions of the perfusion method.: 320-322 [in Slovak].
  5. Cassin S, Kristová V, Davis T, Kadowitz P, Gause G. (1991). Tone-dependent responses to endothelin in the isolated perfused fetal sheep pulmonary circulation in situ.70: 1228-1234.
  6. Chan CC, Reid CM, Aw TJ, Liew D, Haas SJ, Krum H. (2009). Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis.: 2332-2341.
  7. Dedik L, Ďurišová M, Svrček V, Vojtko R, Kristová V, Kriška M. (2003). Computer-based methods for measurement, recording and vessel responses in vitro.: 441-445.
  8. Fick DM, Cooper JW, Wade WE(2003). Updating the Beers criteria for potentially inappropriate medication use in older adults.: 2716-2724.
  9. Gaddi A, Galetti C, Illuminati B, Nascetti S. (1996). Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease.: 389-406.
  10. Kovalčík V. (1963). The response of the isolated ductus arteriosus to oxygen and anoxia.:185-197.
  11. Kristová V, Babál P, Jablonická K, Kriška M. (1995). Study of endothelium-protective effects of sulodexide.: 248
  12. Kristová V, Djibril MN, Fačkovcová D, Kriška M, Kurtanský A. (2002). Comparison of vasoconstrictor responses to selected NSAIDs in rabbit renal and femoral arteries.: 50-53.
  13. Kristová V, Kiss A, Pirnik Z, Kriška M, Ježová D. (2006). Effect of pentoxifylline on endothelaemia and hypothalamic-pituitary-adrenocortical axis activation in female rats under stress exposure.: 81-89.
  14. Kristová V, Kriška M, Babál P, Djibril MN, Slámová J, Kurtanský A. (2000). Evaluation of endothelium-protective effects of drugs in experimental models of endothelial damage.: 123-128.
  15. Kristová V, Kriška M, Caňová R, Hejdová E, Kobzová D, Dobrocký P. (1993). Endothelial changes following repeated effects of vasoconstrictive substances in vitro.: 363-370.
  16. Kristová V, Kriška M, Caňová R. (1986). Reactivity of the fetal and neonatal pulmonary artery in vitro.: 287-294 [in Slovak].
  17. Kristová V, Kriška M, Vojtko R, Kurtanský A. (2000). Effect of indomethacin and deendothelisation on vascular responses in the renal artery.: 129-133.
  18. Kristová V, Líšková S, Sotníková R, Vojtko R, Kurtanský A. (2008). Sulodexide improves endothelial dysfunction in streptozotocin-induced diabetes in rats.: 491-494.
  19. Kriška M, Babál P, Kristová V. (1989). The assessment the reactivity of perfused vessels in relation to the endothelium.: 153 [in Slovak].
  20. Kriška M, Kovalčík V. (1973). Concerning the mechanism of constriction of the arterial duct in response to oxygen.: 145-195 [in Slovak].
  21. Kriška M, Štvrtinová V, Kristova V, Ambrózy E. (2002). Possibilities of pharmacological intervention in derangements of peripheral circulation.: 10-14 [in Slovak].
  22. Lagaud GJ, Masih-Khan E, Kai S, van Breemen C, Dubé GP. (2001). Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries.: 578-589.
  23. Líšková S, Kuneš J, Zicha J (2007). Nifedipine-sensitive vascular reactivity of femoral arteries in WKY: The effects of pertussis toxin pretreatment and endothelium removal.: 663-666.
  24. McLeod PJ, Huang AR, Tamblyn RM(1997). Defining inappropriate practices in prescribing for elderly people: a national consensus panel.: 385-391.
  25. Onder G, Landi F, Liperoti R(2005). Impact of inappropriate drug use among hospitalized older adults.: 453-459.
  26. Rajec J, Tisoňová J, Kriška M, Kristová V, Vojtko R, Dukát A, Ambrózy E, Slyško R, Varga I. (2007). Endothelaemia- a marker of vascular damage.: 403-405.
  27. Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG. (2007). Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.: 149-157.
  28. Smieško V, Kriška M, Kovalčík V. (1978). Bayliss myogenic response in the isolated ductus arteriosus of guinea-pig and rabbit fetuses.: 745-746.
  29. Turnheim K. (2003). When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly.: 843-853.
  30. Varga Z, Kriška M, Kristová V, Hudec. (2010). Prescription of NSAIDs and risk of cardiovascular adverse effects in hospitalized patients. Rheumatologia: 87-90.
  31. Vojtko R., Villaris R., Petrová M., Líšková S., Kristová V. (2010). Modulation of diabetic rat vessel reactivity induced by pycnogenol and sulodexide and its alternative evaluation.: 200-201.
  32. Wawruch M, Fialová D, Žikavská M, Kuželová M, Ježová D, Vinšová J, Kristová V, Topinková E. (2008). Use of potentially inappropriate drugs in elderly patients in the territory of former Czechoslovakia.: 108-112 [in Slovak].
  33. White WB. (2007). Cardiovascular effects of the cyclooxygenase inhibitors.: 408-418.
  34. Zúrová-Nedelčevová J, Navarová J, Drábiková K., Jančinová V, Petríková M, Bernátová I, Kristová V, Šnirc V, Nosáľová V, Sotníková R. (2006). Participation of reactive oxygen species in diabetes - induced endothelial dysfunction.: 168-171.
DOI: https://doi.org/10.2478/v10102-011-0008-8 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 40 - 46
Published on: Apr 18, 2011
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2011 Viera Kristová, Milan Kriška, Róbert Vojtko, Miriam Petrová, Silvia Líšková, Radoslav Villáris, Zoltán Varga, Martin Wawruch, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.